Sharma, Himanshu
Maron, Samuel Z.
Rastinehad, Ardeshir R.
Fischman, Aaron M.
Article History
Received: 3 April 2021
Accepted: 30 July 2021
First Online: 23 August 2021
Declarations
:
: Institutional Review Board (IRB) approval was obtained for this study.
: Not applicable.
: AM Fischman, MD is a paid consultant for Terumo and Boston Scientific; on the advisory board for Terumo, Embolx, and Boston Scientific; a speaker for Terumo and Boston Scientific; provided research support from Boston Scientific; has a royalty agreement with Merit Medical; and is an investor in Adient Medical.None of the other authors have financial disclosures.